Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-07-03

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bupropion hydrochloride from Granules Pharmaceuticals Inc., resulting in an approved change to the product label…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)